Mon. May 25th, 2026
Spread the love

ABUJA – The Senate has approved 516,333,700 dollar syndicated financing facility for the construction of Sokoto–Badagry Super Highway.

This followed the consideration and adoption of the report of the Senate Committee on Local and Foreign Debts during plenary on Wednesday

The approval followed a letter from President Bola Tinubu dated April 20, requesting legislative backing for external borrowing in line with the provisions of the Debt Management Office Establishment Act 2011 and the Fiscal Responsibility Act 2007.

The request was referred to the Senate Committee on Local and Foreign Debt on April 23.

The committee subsequently presented its report recommending approval of the loan.

Sen. Adamu Aliero (APC-Kebbi) presented the report on behalf of the committee’s chairman, Sen. Aliyu Wamakko (APC-Sokoto).

He explained that the facility would finance Section One, Phase One (A and B1) of the highway, covering about 120 kilometres, as part of a broader corridor expected to span approximately 1,000 kilometres from Sokoto to Badagry.

The lawmaker noted that the project was strategically designed to enhance national connectivity by linking Sokoto, Kebbi, Niger, Kwara, Oyo, Ogun and Lagos states.

He described it as a major infrastructure initiative aimed at improving trade, transportation efficiency and national integration.

Aliero further stated that the project would reduce travel time, lower logistics costs, improve access between agricultural zones and markets and strengthen supply chains across key sectors, including agriculture and manufacturing.

According to him, the financing arrangement is structured as a syndicated facility provided by Deutsche Bank, with partial credit enhancement support from the Islamic Corporation for the Insurance of Investment and Export Credit.

He said that the facility has a tenor of nine years, including a grace period of up to three years, with an interest rate benchmarked at CME SOFR plus 5.35 percent per annum.

The senator also noted that although the loan would add to Nigeria’s external debt stock, it was tied to long-term capital development projects expected to generate significant economic returns.

Following the presentation of the report, the request was subjected debate by the senators, with many of them describing the project as a strategic infrastructure link capable of boosting economic growth across geo-political zones.

Sen. Mohammed Monguno (APC-Borno) argued that the project would unlock agricultural and transport value chains, while reducing unemployment and insecurity along the corridor.

Deputy Senate President, Jibrin Barau, emphasised its national integration benefits, noting that it would connect the northern and southern parts of the country more efficiently.

Sen. Adetokunbo Abiru (APC-Lagos) referenced previous loan approvals that had yet to be fully disbursed due to global financial constraints, arguing that the current arrangement provided an alternative funding structure for ongoing projects.

Ruling on the motion, the Senate President, Godswill Akpabio, put the recommendation to a voice vote and it was overwhelmingly adopted.

The senate, thereafter, approved the 516.3 million dollar syndicated loan for the phase one, section one (A and B1) of the project and mandated strict oversight by relevant committees.

The upper chamber also directed quarterly reporting by the Federal Ministry of Finance, Debt Management Office, and Federal Ministry of Works as well as submission of the financing agreement within 30 days.

The lawmakers further stressed the need for transparency, competitive procurement and periodic project evaluation to ensure value for money and timely delivery.

With the approval, the request now awaits transmission to the executive for final processing and implementation.

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.